Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice.
Risk of vascular disease in patients with multiple sclerosis: a review.
Obstructive sleep apnea and fatigue in patients with multiple sclerosis.
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis.
Emerging roles of exosomes in neuron-glia communication.
Correction: Adherence to Interferon β-1b Treatment in Patients with Multiple Sclerosis in Spain.
Subcutaneous interferon β-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
HLA-A(∗)02, gender and tobacco smoking, but not multiple sclerosis, affects the IgG antibody response against human herpesvirus 6.
Historical Issues of Optic neuritis and Sensory Disorder in Persian Traditional Medicine.
The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011.
The pill times 2: What every woman with multiple sclerosis should know.
The translational biology of remyelination: Past, present, and future.
The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.
Genetic burden of common variants in progressive and bout-onset multiple sclerosis.
Neuromuscular taping in multiple sclerosis. A pilot study.
The Arabic version of the Mayo-Portland Adaptability Inventory 4: a validation study.
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.
Myotonic dystrophy type 2 and multiple sclerosis: Case report.
Human papillomavirus vaccination, induced autoimmunity, and neuromyelitis optica.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
Substance Name: Phenytoin
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss.
Pages
« first
‹ previous
…
183
184
185
186
187
188
189
190
191
…
next ›
last »